Bio Usawa is a biotech headquartered in US.
Deals (12mo)
1
Active Trials
0
Top Modality
N/A
Focus Area
N/A
Key indicators of Bio Usawa's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Acquisition Appetite
Use Solidus to benchmark upfront payments, milestones, and royalties — powered by data from 3,500+ real biopharma transactions.
Bio Usawa is a biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Bio Usawa and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Bio Usawa's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.
© 2026 Ambrosia Ventures. All rights reserved.
Benchmarks powered by 1,600+ real biopharma licensing deals